Guidelines for the evaluation of anti-infective drug products:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chicago, Ill.
Univ. of Chicago Press
1992
|
| Schriftenreihe: | Clinical infectious diseases / Supplement
15,1 |
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | 346 S. |
| ISSN: | 1058-4838 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV005881754 | ||
| 003 | DE-604 | ||
| 005 | 19921208 | ||
| 007 | t | ||
| 008 | 921203s1992 |||| 00||| eng d | ||
| 035 | |a (OCoLC)27300136 | ||
| 035 | |a (DE-599)BVBBV005881754 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 |a DE-20 | ||
| 050 | 0 | |a RM301.27 | |
| 245 | 1 | 0 | |a Guidelines for the evaluation of anti-infective drug products |c guest ed.: Thomas R. Beam ... |
| 264 | 1 | |a Chicago, Ill. |b Univ. of Chicago Press |c 1992 | |
| 300 | |a 346 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Clinical infectious diseases / Supplement |v 15,1 |x 1058-4838 | |
| 500 | |a Literaturangaben | ||
| 650 | 7 | |a Antibiotica |2 gtt | |
| 650 | 7 | |a Antivirusmiddelen |2 gtt | |
| 650 | 7 | |a Evaluatie |2 gtt | |
| 650 | 4 | |a Anti-Infective Agents |x standards |z United States | |
| 650 | 4 | |a Clinical Trials |x standards |z United States | |
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Drug Evaluation |x standards |z United States | |
| 650 | 4 | |a Drugs |x Testing | |
| 650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Forschungsmethode |0 (DE-588)4155046-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
| 689 | 1 | 1 | |a Forschungsmethode |0 (DE-588)4155046-8 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Beam, Thomas R. |e Sonstige |4 oth | |
| 810 | 2 | |a Supplement |t Clinical infectious diseases |v 15,1 |w (DE-604)BV004765736 |9 15,1 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003683156 | ||
Datensatz im Suchindex
| _version_ | 1804120072280604674 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV005881754 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.27 |
| callnumber-search | RM301.27 |
| callnumber-sort | RM 3301.27 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)27300136 (DE-599)BVBBV005881754 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01734nam a2200493 cb4500</leader><controlfield tag="001">BV005881754</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19921208 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921203s1992 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)27300136</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005881754</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.27</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Guidelines for the evaluation of anti-infective drug products</subfield><subfield code="c">guest ed.: Thomas R. Beam ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago, Ill.</subfield><subfield code="b">Univ. of Chicago Press</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">346 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Clinical infectious diseases / Supplement</subfield><subfield code="v">15,1</subfield><subfield code="x">1058-4838</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antibiotica</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antivirusmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Evaluatie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Infective Agents</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsmethode</subfield><subfield code="0">(DE-588)4155046-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Forschungsmethode</subfield><subfield code="0">(DE-588)4155046-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beam, Thomas R.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Clinical infectious diseases</subfield><subfield code="v">15,1</subfield><subfield code="w">(DE-604)BV004765736</subfield><subfield code="9">15,1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003683156</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV005881754 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T16:36:16Z |
| institution | BVB |
| issn | 1058-4838 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003683156 |
| oclc_num | 27300136 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-12 DE-20 |
| physical | 346 S. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Univ. of Chicago Press |
| record_format | marc |
| series2 | Clinical infectious diseases / Supplement |
| spelling | Guidelines for the evaluation of anti-infective drug products guest ed.: Thomas R. Beam ... Chicago, Ill. Univ. of Chicago Press 1992 346 S. txt rdacontent n rdamedia nc rdacarrier Clinical infectious diseases / Supplement 15,1 1058-4838 Literaturangaben Antibiotica gtt Antivirusmiddelen gtt Evaluatie gtt Anti-Infective Agents standards United States Clinical Trials standards United States Clinical trials Drug Evaluation standards United States Drugs Testing Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf Forschungsmethode (DE-588)4155046-8 gnd rswk-swf Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf USA Arzneimittelprüfung (DE-588)4128030-1 s DE-604 Arzneimittelsicherheit (DE-588)4143182-0 s Forschungsmethode (DE-588)4155046-8 s Beam, Thomas R. Sonstige oth Supplement Clinical infectious diseases 15,1 (DE-604)BV004765736 15,1 |
| spellingShingle | Guidelines for the evaluation of anti-infective drug products Antibiotica gtt Antivirusmiddelen gtt Evaluatie gtt Anti-Infective Agents standards United States Clinical Trials standards United States Clinical trials Drug Evaluation standards United States Drugs Testing Arzneimittelsicherheit (DE-588)4143182-0 gnd Forschungsmethode (DE-588)4155046-8 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd |
| subject_GND | (DE-588)4143182-0 (DE-588)4155046-8 (DE-588)4128030-1 |
| title | Guidelines for the evaluation of anti-infective drug products |
| title_auth | Guidelines for the evaluation of anti-infective drug products |
| title_exact_search | Guidelines for the evaluation of anti-infective drug products |
| title_full | Guidelines for the evaluation of anti-infective drug products guest ed.: Thomas R. Beam ... |
| title_fullStr | Guidelines for the evaluation of anti-infective drug products guest ed.: Thomas R. Beam ... |
| title_full_unstemmed | Guidelines for the evaluation of anti-infective drug products guest ed.: Thomas R. Beam ... |
| title_short | Guidelines for the evaluation of anti-infective drug products |
| title_sort | guidelines for the evaluation of anti infective drug products |
| topic | Antibiotica gtt Antivirusmiddelen gtt Evaluatie gtt Anti-Infective Agents standards United States Clinical Trials standards United States Clinical trials Drug Evaluation standards United States Drugs Testing Arzneimittelsicherheit (DE-588)4143182-0 gnd Forschungsmethode (DE-588)4155046-8 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd |
| topic_facet | Antibiotica Antivirusmiddelen Evaluatie Anti-Infective Agents standards United States Clinical Trials standards United States Clinical trials Drug Evaluation standards United States Drugs Testing Arzneimittelsicherheit Forschungsmethode Arzneimittelprüfung USA |
| volume_link | (DE-604)BV004765736 |
| work_keys_str_mv | AT beamthomasr guidelinesfortheevaluationofantiinfectivedrugproducts |